These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2855330

  • 1. Comparison between the cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and clonidine in the conscious sino-aortic denervated rat.
    Petty MA, Kintz J, Di Francesco GF, Fozard JR.
    J Auton Pharmacol; 1988 Dec; 8(4):267-76. PubMed ID: 2855330
    [Abstract] [Full Text] [Related]

  • 2. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
    Gradin K, Pettersson A, Hedner T, Persson B.
    J Neural Transm; 1985 Dec; 62(3-4):305-19. PubMed ID: 3161997
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
    Bouhelal R, Loubatières-Mariani MM, Mir AK.
    Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614
    [Abstract] [Full Text] [Related]

  • 6. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F, Jeanrenaud B.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
    Doods HN, Boddeke HW, Kalkman HO, Hoyer D, Mathy MJ, van Zwieten PA.
    J Cardiovasc Pharmacol; 1988 Apr 06; 11(4):432-7. PubMed ID: 2453746
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA, Martin KF.
    Br J Pharmacol; 1986 Oct 06; 89(2):277-86. PubMed ID: 2430656
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Systemic and regional haemodynamic responses to microinjection of 5-HT agonists in the rostral ventrolateral medulla in the rat.
    Lovick TA.
    Neurosci Lett; 1989 Dec 15; 107(1-3):157-61. PubMed ID: 2533333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.